Literature DB >> 34007693

An Exploratory Survey of Incorporation of Gender- and Sex-related Differences in the PharmD Curricula.

Kelsea Caruso1, Brooke Griffin1, Kathleen Vest1, Spencer E Harpe1.   

Abstract

INTRODUCTION: Clinical presentation and treatment in many disease states vary due to sex- and gender-differences. Sex-related pharmacokinetic differences are particularly important for pharmacists. The Accreditation Council for Pharmacy Education (ACPE) currently has no standard for the inclusion of gender- and sex-related differences in the didactic PharmD curriculum, but encourages advanced pharmacy practice experiences (APPEs) to include diverse populations related to gender. The purpose of this survey is to explore faculty incorporation of gender and sex differences within the PharmD didactic curriculum in preparation for a nation-wide survey.
METHODS: A survey was created to determine how many clinical topics incorporated gender- and sex-related differences and to what extent this information was discussed in the classroom. The survey link was emailed to pharmacotherapeutics and pharmacokinetics faculty at Midwestern University Chicago College of Pharmacy, University of Illinois at Chicago, Roosevelt University, Rosalind Franklin University, and Chicago State University. Chi square analyses were performed to examine relationships across participant responses.
RESULTS: A total of 56 faculty members participated in the survey, resulting in a 20% response rate. Of these, 30 (54.5%) faculty indicated that they discussed gender- and sex-related differences in the subject area in which they teach. Approximately 33% of respondents found gender- and sex-related differences very clinically important. Gender- and sex- related differences were taught in a variety of subject areas, including cardiology, diabetes, and chronic obstructive pulmonary disease (COPD).
CONCLUSION: With no current standard, faculty members independently choose to include gender- and sex-related differences in their lecture topics and the extent of the discussion. Faculty should be aware of this lack of standardization and that they are independently responsible for including gender- and sex-related differences in their particular topics. Because the surveyed faculty find gender- and sex-related differences clinically important and literature suggests differences in medications depending on gender and sex, further research is planned to provide insight on a national level. © University of Minnesota Libraries Publishing.

Entities:  

Keywords:  gender differences; pharmacodynamics; pharmacokinetics; pharmacy education; sex differences; women’s health

Year:  2018        PMID: 34007693      PMCID: PMC6438549          DOI: 10.24926/iip.v9i2.938

Source DB:  PubMed          Journal:  Innov Pharm        ISSN: 2155-0417


  8 in total

1.  Lesbian, gay, bisexual, and transgender-related content in undergraduate medical education.

Authors:  Juno Obedin-Maliver; Elizabeth S Goldsmith; Leslie Stewart; William White; Eric Tran; Stephanie Brenman; Maggie Wells; David M Fetterman; Gabriel Garcia; Mitchell R Lunn
Journal:  JAMA       Date:  2011-09-07       Impact factor: 56.272

2.  Age and sex differences in the treatment of patients with initial acute myocardial infarction: a community-wide perspective.

Authors:  Leslie R Harrold; Darleen Lessard; Jorge Yarzebski; Jerry H Gurwitz; Joel M Gore; Robert J Goldberg
Journal:  Cardiology       Date:  2003       Impact factor: 1.869

3.  Women's early warning symptoms of acute myocardial infarction.

Authors:  Jean C McSweeney; Marisue Cody; Patricia O'Sullivan; Karen Elberson; Debra K Moser; Bonnie J Garvin
Journal:  Circulation       Date:  2003-11-03       Impact factor: 29.690

4.  Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence.

Authors:  R C Kessler; K A McGonagle; M Swartz; D G Blazer; C B Nelson
Journal:  J Affect Disord       Date:  1993 Oct-Nov       Impact factor: 4.839

5.  Development and validation of a clinical prediction rule for angiotensin-converting enzyme inhibitor-induced cough.

Authors:  Takeshi Morimoto; Tejal K Gandhi; Julie M Fiskio; Andrew C Seger; Joseph W So; E Francis Cook; Tsuguya Fukui; David W Bates
Journal:  J Gen Intern Med       Date:  2004-06       Impact factor: 5.128

6.  The experience of symptoms of depression in men vs women: analysis of the National Comorbidity Survey Replication.

Authors:  Lisa A Martin; Harold W Neighbors; Derek M Griffith
Journal:  JAMA Psychiatry       Date:  2013-10       Impact factor: 21.596

Review 7.  The influence of sex on pharmacokinetics.

Authors:  Janice B Schwartz
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 5.577

8.  Sex differences in plasma clozapine and norclozapine concentrations in clinical practice and in relation to body mass index and plasma glucose concentrations: a retrospective survey.

Authors:  Simon G Anderson; Mark Livingston; Lewis Couchman; Daniel J Smith; Moira Connolly; Joan Miller; Robert J Flanagan; A H Heald
Journal:  Ann Gen Psychiatry       Date:  2015-11-14       Impact factor: 3.455

  8 in total
  1 in total

1.  The importance of providing gender-affirming care in pharmacy practice.

Authors:  Lucille M Abrams; Kevin Look; Lisa Imhoff
Journal:  Explor Res Clin Soc Pharm       Date:  2022-04-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.